Olivier Laurent

Company: Prometheus Biosciences

Job title: CSO

Seminars:

Identifying New IBD Drug Targets & Accompanying Patient Stratification Biomarkers From Large Multi-Modal Datasets 5:00 pm

Discussing the importance and power of large multi-model datasets to identify new therapeutic targets in IBD Reviewing Anti-TL1A and anti-CD30L precision medicine case studies to highlight the need for patient stratification Identifying genomic variants as patient stratification biomarkersRead more

day: Day One

Panel Discussion: Exploring More Objective Ways of Classifying IBD Subtypes to Improve Patient Stratification 11:00 am

A session dedicated to discussing the future of risk-classifying IBD patients and tackling the need for more objective classifications. Discovering genetic signatures, microbiome patterns and proteomic indicators to formulate more homogenous patient groups to increase therapeutic efficacy within that patient group Exploring novel scores to effectively measure burden of disease to better understand the patient…Read more

day: Day One